

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.47393728 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.47393728 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.59364293 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.98156524 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 4.98156524 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.98156524 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.98156524 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.98156524 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.98156524 |
| 10 | negative T cell selection (GO:0043383) | 4.86415235 |
| 11 | negative thymic T cell selection (GO:0045060) | 4.86041595 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.84309283 |
| 13 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.44135316 |
| 14 | detection of other organism (GO:0098543) | 4.43324541 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.42316927 |
| 16 | detection of bacterium (GO:0016045) | 4.38836955 |
| 17 | response to interleukin-15 (GO:0070672) | 4.36517637 |
| 18 | leukocyte aggregation (GO:0070486) | 4.28722333 |
| 19 | B cell receptor signaling pathway (GO:0050853) | 4.23186973 |
| 20 | negative regulation of T cell mediated immunity (GO:0002710) | 4.18513270 |
| 21 | cellular response to interleukin-15 (GO:0071350) | 4.13852918 |
| 22 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.13145027 |
| 23 | T cell migration (GO:0072678) | 4.12697550 |
| 24 | cellular response to type I interferon (GO:0071357) | 4.04929980 |
| 25 | type I interferon signaling pathway (GO:0060337) | 4.04929980 |
| 26 | response to type I interferon (GO:0034340) | 4.00510494 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 3.98883531 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.96299861 |
| 29 | tolerance induction (GO:0002507) | 3.95603655 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.93979419 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.93979419 |
| 32 | T cell selection (GO:0045058) | 3.82875184 |
| 33 | positive T cell selection (GO:0043368) | 3.80992187 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.80711108 |
| 35 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.79911623 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.79742669 |
| 37 | cellular extravasation (GO:0045123) | 3.77878336 |
| 38 | regulation of T cell tolerance induction (GO:0002664) | 3.77564556 |
| 39 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.76744168 |
| 40 | response to peptidoglycan (GO:0032494) | 3.68988387 |
| 41 | thymic T cell selection (GO:0045061) | 3.68943396 |
| 42 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.65414948 |
| 43 | detection of external biotic stimulus (GO:0098581) | 3.59935092 |
| 44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57871981 |
| 45 | response to host immune response (GO:0052572) | 3.56916665 |
| 46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.56916665 |
| 47 | activated T cell proliferation (GO:0050798) | 3.54002666 |
| 48 | regulation of tolerance induction (GO:0002643) | 3.52565619 |
| 49 | ribosomal small subunit assembly (GO:0000028) | 3.50787945 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.50550646 |
| 51 | response to muramyl dipeptide (GO:0032495) | 3.45296065 |
| 52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.43452962 |
| 53 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.41582555 |
| 54 | defense response to protozoan (GO:0042832) | 3.37299249 |
| 55 | microglial cell activation (GO:0001774) | 3.32032696 |
| 56 | response to host (GO:0075136) | 3.30253754 |
| 57 | response to host defenses (GO:0052200) | 3.30253754 |
| 58 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.30253754 |
| 59 | B cell mediated immunity (GO:0019724) | 3.30237819 |
| 60 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.24443161 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.23605685 |
| 62 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.23551065 |
| 63 | B cell homeostasis (GO:0001782) | 3.22498997 |
| 64 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.21422784 |
| 65 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.21422784 |
| 66 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.19784526 |
| 67 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.19214735 |
| 68 | mast cell activation (GO:0045576) | 3.18566219 |
| 69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.18038457 |
| 70 | positive regulation of tolerance induction (GO:0002645) | 3.17796758 |
| 71 | detection of molecule of bacterial origin (GO:0032490) | 3.17491011 |
| 72 | detection of biotic stimulus (GO:0009595) | 3.16487298 |
| 73 | positive regulation of granulocyte differentiation (GO:0030854) | 3.16045140 |
| 74 | regulation of regulatory T cell differentiation (GO:0045589) | 3.15965794 |
| 75 | respiratory burst (GO:0045730) | 3.15511736 |
| 76 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.14771736 |
| 77 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.14501137 |
| 78 | positive regulation of humoral immune response (GO:0002922) | 3.13964907 |
| 79 | germinal center formation (GO:0002467) | 3.13420668 |
| 80 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.12839770 |
| 81 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.10735055 |
| 82 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.10501894 |
| 83 | neutrophil activation (GO:0042119) | 3.10428579 |
| 84 | interferon-gamma production (GO:0032609) | 3.08710416 |
| 85 | NIK/NF-kappaB signaling (GO:0038061) | 3.08527543 |
| 86 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.06444670 |
| 87 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.03843557 |
| 88 | positive regulation of B cell differentiation (GO:0045579) | 3.03711405 |
| 89 | response to protozoan (GO:0001562) | 3.02307799 |
| 90 | myeloid dendritic cell activation (GO:0001773) | 3.02201955 |
| 91 | T cell receptor signaling pathway (GO:0050852) | 2.99717146 |
| 92 | telomere maintenance via recombination (GO:0000722) | 2.99555448 |
| 93 | T cell homeostasis (GO:0043029) | 2.96942133 |
| 94 | negative regulation of adaptive immune response (GO:0002820) | 2.96534931 |
| 95 | DNA strand elongation (GO:0022616) | 2.96148045 |
| 96 | lymphocyte homeostasis (GO:0002260) | 2.95409350 |
| 97 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.94950872 |
| 98 | regulation of RIG-I signaling pathway (GO:0039535) | 2.88655971 |
| 99 | negative regulation of phagocytosis (GO:0050765) | 2.88174386 |
| 100 | DNA unwinding involved in DNA replication (GO:0006268) | 2.79631223 |
| 101 | necroptotic process (GO:0070266) | 2.77782049 |
| 102 | definitive hemopoiesis (GO:0060216) | 2.74524083 |
| 103 | mitotic recombination (GO:0006312) | 2.73406770 |
| 104 | lysine catabolic process (GO:0006554) | 2.73113028 |
| 105 | lysine metabolic process (GO:0006553) | 2.73113028 |
| 106 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.69613906 |
| 107 | hepatocyte apoptotic process (GO:0097284) | 2.65107850 |
| 108 | pentose-phosphate shunt (GO:0006098) | 2.64218962 |
| 109 | regulation of necroptotic process (GO:0060544) | 2.60692278 |
| 110 | NADPH regeneration (GO:0006740) | 2.60496884 |
| 111 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.58763239 |
| 112 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.57117440 |
| 113 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.56583601 |
| 114 | DNA replication initiation (GO:0006270) | 2.54096636 |
| 115 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.45962800 |
| 116 | signal peptide processing (GO:0006465) | 2.42032750 |
| 117 | CENP-A containing nucleosome assembly (GO:0034080) | 2.39729521 |
| 118 | T cell apoptotic process (GO:0070231) | 2.39462191 |
| 119 | viral transcription (GO:0019083) | 2.39087288 |
| 120 | translational termination (GO:0006415) | 2.36877627 |
| 121 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.35957679 |
| 122 | negative regulation of necroptotic process (GO:0060546) | 2.35869846 |
| 123 | neutrophil activation involved in immune response (GO:0002283) | 2.35683981 |
| 124 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.34171607 |
| 125 | cellular response to zinc ion (GO:0071294) | 2.33358205 |
| 126 | valine metabolic process (GO:0006573) | 2.32457574 |
| 127 | positive regulation of interferon-alpha production (GO:0032727) | 2.32315445 |
| 128 | protein localization to kinetochore (GO:0034501) | 2.30555047 |
| 129 | 2-oxoglutarate metabolic process (GO:0006103) | 2.26831096 |
| 130 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.25669934 |
| 131 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.25348285 |
| 132 | purine-containing compound salvage (GO:0043101) | 2.25283310 |
| 133 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.24808485 |
| 134 | DNA replication checkpoint (GO:0000076) | 2.23685963 |
| 135 | folic acid metabolic process (GO:0046655) | 2.23396737 |
| 136 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.22136718 |
| 137 | tricarboxylic acid cycle (GO:0006099) | 2.20947691 |
| 138 | chromatin remodeling at centromere (GO:0031055) | 2.20757181 |
| 139 | histone-serine phosphorylation (GO:0035404) | 2.20564828 |
| 140 | translational elongation (GO:0006414) | 2.19691225 |
| 141 | regulation of B cell differentiation (GO:0045577) | 2.19335965 |
| 142 | glyoxylate metabolic process (GO:0046487) | 2.19176372 |
| 143 | cotranslational protein targeting to membrane (GO:0006613) | 2.16979517 |
| 144 | protein targeting to ER (GO:0045047) | 2.16713793 |
| 145 | mitotic chromosome condensation (GO:0007076) | 2.16208874 |
| 146 | aldehyde catabolic process (GO:0046185) | 2.16147165 |
| 147 | programmed necrotic cell death (GO:0097300) | 2.16112254 |
| 148 | regulation of necrotic cell death (GO:0010939) | 2.15836989 |
| 149 | regulation of interferon-alpha production (GO:0032647) | 2.14858515 |
| 150 | AMP metabolic process (GO:0046033) | 2.14460569 |
| 151 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.13476104 |
| 152 | telomere maintenance via telomere lengthening (GO:0010833) | 2.13126033 |
| 153 | mitochondrial calcium ion transport (GO:0006851) | 2.12510053 |
| 154 | IMP metabolic process (GO:0046040) | 2.11375924 |
| 155 | megakaryocyte development (GO:0035855) | 2.10293376 |
| 156 | protein localization to endoplasmic reticulum (GO:0070972) | 2.09095928 |
| 157 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.08333129 |
| 158 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.08084055 |
| 159 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.08047966 |
| 160 | purine nucleobase metabolic process (GO:0006144) | 2.07696208 |
| 161 | heart process (GO:0003015) | 2.07405957 |
| 162 | heart contraction (GO:0060047) | 2.07405957 |
| 163 | nucleobase biosynthetic process (GO:0046112) | 2.07271060 |
| 164 | purine nucleobase biosynthetic process (GO:0009113) | 2.07094434 |
| 165 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.06228136 |
| 166 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.06116333 |
| 167 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.06116333 |
| 168 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.05605065 |
| 169 | oxaloacetate metabolic process (GO:0006107) | 2.04880781 |
| 170 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.04374008 |
| 171 | cellular glucuronidation (GO:0052695) | 2.04152400 |
| 172 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.03394309 |
| 173 | serine family amino acid biosynthetic process (GO:0009070) | 2.02263032 |
| 174 | response to interferon-beta (GO:0035456) | 2.02192593 |
| 175 | uronic acid metabolic process (GO:0006063) | 2.02139837 |
| 176 | glucuronate metabolic process (GO:0019585) | 2.02139837 |
| 177 | glucose catabolic process (GO:0006007) | 2.00571011 |
| 178 | regulation of response to interferon-gamma (GO:0060330) | 2.00559401 |
| 179 | tricarboxylic acid metabolic process (GO:0072350) | 2.00544026 |
| 180 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 1.99529537 |
| 181 | actin nucleation (GO:0045010) | 1.99522068 |
| 182 | mitotic nuclear envelope disassembly (GO:0007077) | 1.99167665 |
| 183 | protein localization to chromosome, centromeric region (GO:0071459) | 1.99036957 |
| 184 | mitotic metaphase plate congression (GO:0007080) | 1.98633630 |
| 185 | lymphocyte apoptotic process (GO:0070227) | 1.97668779 |
| 186 | telomere maintenance (GO:0000723) | 1.96844218 |
| 187 | immunoglobulin mediated immune response (GO:0016064) | 1.96707560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.81621291 |
| 2 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.44922770 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.15061568 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.86050776 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.84482373 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.53393920 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.47284733 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.41373382 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31606960 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.30749046 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.27441244 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.25391211 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.24892737 |
| 14 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.22723460 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.18421266 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.17833225 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.15499388 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.13369898 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.10658037 |
| 20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.10102369 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.05543248 |
| 22 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.03569312 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.02057388 |
| 24 | MAF_26560356_Chip-Seq_TH2_Human | 2.00265341 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.97856342 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97583003 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.95530064 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.94609494 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.93102112 |
| 30 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.92739525 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.88453081 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88092716 |
| 33 | GATA3_26560356_Chip-Seq_TH2_Human | 1.84019391 |
| 34 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.82663698 |
| 35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.82149189 |
| 36 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.79625645 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78179905 |
| 38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75690850 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.74140337 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71995446 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71878756 |
| 42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.70026448 |
| 43 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.69650704 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69072592 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.69017604 |
| 46 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.68895824 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.67667259 |
| 48 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.63453663 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.61876174 |
| 50 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61263912 |
| 51 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.58555466 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.56598522 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54395748 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54130877 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53959208 |
| 56 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53497890 |
| 57 | MYB_26560356_Chip-Seq_TH2_Human | 1.52892464 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.50910897 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49884647 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.48533778 |
| 61 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48490364 |
| 62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.48487868 |
| 63 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.48424305 |
| 64 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.47960292 |
| 65 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.47070593 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46477455 |
| 67 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45829333 |
| 68 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.44385819 |
| 69 | MYC_22102868_ChIP-Seq_BL_Human | 1.43754609 |
| 70 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.43692830 |
| 71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.43340009 |
| 72 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42877449 |
| 73 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.41738189 |
| 74 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.39434337 |
| 75 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.38423510 |
| 76 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.33979798 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33568613 |
| 78 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31845773 |
| 79 | MYB_26560356_Chip-Seq_TH1_Human | 1.31384956 |
| 80 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30719266 |
| 81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30680084 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30404289 |
| 83 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28940015 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28391977 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28135657 |
| 86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27746946 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27683517 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27494453 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.27458204 |
| 90 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25642840 |
| 91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.24887619 |
| 92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23073024 |
| 93 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22924352 |
| 94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22883449 |
| 95 | MAF_26560356_Chip-Seq_TH1_Human | 1.22232214 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.21551785 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19809603 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19660402 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18625025 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18089507 |
| 101 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17720055 |
| 102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17159649 |
| 103 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16914768 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16277876 |
| 105 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.15916622 |
| 106 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14608840 |
| 107 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13574374 |
| 108 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12880246 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12726497 |
| 110 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12129888 |
| 111 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.12061059 |
| 112 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12020676 |
| 113 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11426197 |
| 114 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10289992 |
| 115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10041762 |
| 116 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08051884 |
| 117 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.07879770 |
| 118 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07116178 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06527084 |
| 120 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04875343 |
| 121 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02994244 |
| 122 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02637886 |
| 123 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02161795 |
| 124 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.00016988 |
| 125 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99893850 |
| 126 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.99587200 |
| 127 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98940660 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98641623 |
| 129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97605908 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95614532 |
| 131 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94299379 |
| 132 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93518260 |
| 133 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92808584 |
| 134 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92602373 |
| 135 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.91136387 |
| 136 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87958215 |
| 137 | GATA3_26560356_Chip-Seq_TH1_Human | 0.87841850 |
| 138 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85328755 |
| 139 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84539517 |
| 140 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84416120 |
| 141 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80745170 |
| 142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79299731 |
| 143 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78416583 |
| 144 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78062423 |
| 145 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77082550 |
| 146 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76905350 |
| 147 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74150709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.41097359 |
| 2 | MP0002396_abnormal_hematopoietic_system | 2.77431188 |
| 3 | MP0006054_spinal_hemorrhage | 2.65381837 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 2.39097782 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.35442308 |
| 6 | MP0005360_urolithiasis | 2.18569305 |
| 7 | MP0003656_abnormal_erythrocyte_physiolo | 2.17062838 |
| 8 | MP0003693_abnormal_embryo_hatching | 1.91169182 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 1.87674645 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 1.80009082 |
| 11 | MP0009785_altered_susceptibility_to | 1.77946465 |
| 12 | MP0005310_abnormal_salivary_gland | 1.72089640 |
| 13 | MP0003436_decreased_susceptibility_to | 1.68995449 |
| 14 | MP0010094_abnormal_chromosome_stability | 1.62689932 |
| 15 | MP0003186_abnormal_redox_activity | 1.62547303 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 1.62381715 |
| 17 | MP0003866_abnormal_defecation | 1.61788208 |
| 18 | MP0003763_abnormal_thymus_physiology | 1.59849879 |
| 19 | MP0005671_abnormal_response_to | 1.59623771 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.58682223 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 1.58682223 |
| 22 | MP0000685_abnormal_immune_system | 1.57462209 |
| 23 | MP0005365_abnormal_bile_salt | 1.56764062 |
| 24 | MP0002166_altered_tumor_susceptibility | 1.54762228 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 1.49875227 |
| 26 | MP0001800_abnormal_humoral_immune | 1.49774927 |
| 27 | MP0009840_abnormal_foam_cell | 1.47572843 |
| 28 | MP0003724_increased_susceptibility_to | 1.46992256 |
| 29 | MP0008260_abnormal_autophagy | 1.46936288 |
| 30 | MP0002419_abnormal_innate_immunity | 1.46596966 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.46216963 |
| 32 | MP0002398_abnormal_bone_marrow | 1.45693080 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.43451563 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.42231094 |
| 35 | MP0003646_muscle_fatigue | 1.39121309 |
| 36 | MP0005025_abnormal_response_to | 1.38897073 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.37272516 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.36497584 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.36335564 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.35837028 |
| 41 | MP0004381_abnormal_hair_follicle | 1.34589570 |
| 42 | MP0004957_abnormal_blastocyst_morpholog | 1.34506495 |
| 43 | MP0003221_abnormal_cardiomyocyte_apopto | 1.34339662 |
| 44 | MP0003077_abnormal_cell_cycle | 1.33913854 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.33655805 |
| 46 | MP0003828_pulmonary_edema | 1.32247064 |
| 47 | MP0002722_abnormal_immune_system | 1.30884124 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.30342453 |
| 49 | MP0001851_eye_inflammation | 1.29699042 |
| 50 | MP0002723_abnormal_immune_serum | 1.29386283 |
| 51 | MP0001819_abnormal_immune_cell | 1.28157591 |
| 52 | MP0008007_abnormal_cellular_replicative | 1.27037368 |
| 53 | MP0000716_abnormal_immune_system | 1.23143292 |
| 54 | MP0005451_abnormal_body_composition | 1.21064659 |
| 55 | MP0001853_heart_inflammation | 1.20262919 |
| 56 | MP0005387_immune_system_phenotype | 1.18688186 |
| 57 | MP0001790_abnormal_immune_system | 1.18688186 |
| 58 | MP0008057_abnormal_DNA_replication | 1.18481583 |
| 59 | MP0000343_altered_response_to | 1.18447812 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.17896154 |
| 61 | MP0004084_abnormal_cardiac_muscle | 1.17377019 |
| 62 | MP0004147_increased_porphyrin_level | 1.16954067 |
| 63 | MP0002429_abnormal_blood_cell | 1.16790219 |
| 64 | MP0008469_abnormal_protein_level | 1.15772448 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.15766531 |
| 66 | MP0002933_joint_inflammation | 1.14717437 |
| 67 | MP0003111_abnormal_nucleus_morphology | 1.14395984 |
| 68 | MP0002006_tumorigenesis | 1.14294642 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.13880329 |
| 70 | MP0002019_abnormal_tumor_incidence | 1.12618619 |
| 71 | MP0010155_abnormal_intestine_physiology | 1.12125139 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.09561309 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 1.09170864 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.08986345 |
| 75 | MP0003183_abnormal_peptide_metabolism | 1.08459807 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 1.08179723 |
| 77 | MP0009697_abnormal_copulation | 1.07547465 |
| 78 | MP0000609_abnormal_liver_physiology | 1.07546576 |
| 79 | MP0000490_abnormal_crypts_of | 1.07255396 |
| 80 | MP0004883_abnormal_blood_vessel | 1.05707683 |
| 81 | MP0002132_abnormal_respiratory_system | 1.05698590 |
| 82 | MP0002405_respiratory_system_inflammati | 1.04523771 |
| 83 | MP0001873_stomach_inflammation | 1.03059515 |
| 84 | MP0003252_abnormal_bile_duct | 1.02366998 |
| 85 | MP0009278_abnormal_bone_marrow | 1.01243085 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 1.00931705 |
| 87 | MP0010307_abnormal_tumor_latency | 1.00509154 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 0.99541245 |
| 89 | MP0005275_abnormal_skin_tensile | 0.99234090 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.98460287 |
| 91 | MP0000598_abnormal_liver_morphology | 0.98396924 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.98207181 |
| 93 | MP0010368_abnormal_lymphatic_system | 0.95329667 |
| 94 | MP0010329_abnormal_lipoprotein_level | 0.94595551 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.94555199 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.93281330 |
| 97 | MP0003279_aneurysm | 0.92493088 |
| 98 | MP0006082_CNS_inflammation | 0.91207371 |
| 99 | MP0003300_gastrointestinal_ulcer | 0.90948621 |
| 100 | MP0003705_abnormal_hypodermis_morpholog | 0.90819058 |
| 101 | MP0009763_increased_sensitivity_to | 0.89550871 |
| 102 | MP0000749_muscle_degeneration | 0.89071133 |
| 103 | MP0004947_skin_inflammation | 0.88180089 |
| 104 | MP0005408_hypopigmentation | 0.87436668 |
| 105 | MP0001663_abnormal_digestive_system | 0.87202679 |
| 106 | MP0004510_myositis | 0.86971048 |
| 107 | MP0002009_preneoplasia | 0.86695851 |
| 108 | MP0000858_altered_metastatic_potential | 0.86380816 |
| 109 | MP0002837_dystrophic_cardiac_calcinosis | 0.85581973 |
| 110 | MP0005330_cardiomyopathy | 0.84410833 |
| 111 | MP0004036_abnormal_muscle_relaxation | 0.84364578 |
| 112 | MP0005023_abnormal_wound_healing | 0.83637395 |
| 113 | MP0009764_decreased_sensitivity_to | 0.82497175 |
| 114 | MP0005503_abnormal_tendon_morphology | 0.82176469 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.81735297 |
| 116 | MP0005332_abnormal_amino_acid | 0.81205928 |
| 117 | MP0005166_decreased_susceptibility_to | 0.79722060 |
| 118 | MP0001348_abnormal_lacrimal_gland | 0.78397360 |
| 119 | MP0003172_abnormal_lysosome_physiology | 0.77881048 |
| 120 | MP0003045_fibrosis | 0.76858552 |
| 121 | MP0003448_altered_tumor_morphology | 0.73796906 |
| 122 | MP0000249_abnormal_blood_vessel | 0.71038803 |
| 123 | MP0005164_abnormal_response_to | 0.67579629 |
| 124 | MP0003075_altered_response_to | 0.65874156 |
| 125 | MP0000015_abnormal_ear_pigmentation | 0.62887495 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.62173274 |
| 127 | MP0003091_abnormal_cell_migration | 0.59983985 |
| 128 | MP0001986_abnormal_taste_sensitivity | 0.59089440 |
| 129 | MP0008004_abnormal_stomach_pH | 0.57639205 |
| 130 | MP0002928_abnormal_bile_duct | 0.57485998 |
| 131 | MP0005390_skeleton_phenotype | 0.55924568 |
| 132 | MP0008961_abnormal_basal_metabolism | 0.53496964 |
| 133 | MP0003795_abnormal_bone_structure | 0.52079186 |
| 134 | MP0000569_abnormal_digit_pigmentation | 0.51364108 |
| 135 | MP0002693_abnormal_pancreas_physiology | 0.49910425 |
| 136 | MP0008877_abnormal_DNA_methylation | 0.48452579 |
| 137 | MP0003690_abnormal_glial_cell | 0.45848627 |
| 138 | MP0008874_decreased_physiological_sensi | 0.44819061 |
| 139 | MP0000313_abnormal_cell_death | 0.43565535 |
| 140 | MP0009115_abnormal_fat_cell | 0.43229175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.18425545 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 4.70092439 |
| 3 | Optic neuritis (HP:0100653) | 4.70092439 |
| 4 | Meningitis (HP:0001287) | 4.60420795 |
| 5 | Stomatitis (HP:0010280) | 4.53805812 |
| 6 | Recurrent cutaneous fungal infections (HP:0011370) | 4.30066930 |
| 7 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.30066930 |
| 8 | Vasculitis (HP:0002633) | 4.27649363 |
| 9 | Panhypogammaglobulinemia (HP:0003139) | 4.27402041 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.24826914 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.24743331 |
| 12 | Encephalitis (HP:0002383) | 4.01405709 |
| 13 | Agammaglobulinemia (HP:0004432) | 3.85877413 |
| 14 | Thrombocytosis (HP:0001894) | 3.73626396 |
| 15 | Increased IgM level (HP:0003496) | 3.72823527 |
| 16 | Obstructive lung disease (HP:0006536) | 3.70580860 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.70580860 |
| 18 | Recurrent skin infections (HP:0001581) | 3.65588686 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.55421698 |
| 20 | Pulmonary infiltrates (HP:0002113) | 3.53331142 |
| 21 | Increased IgE level (HP:0003212) | 3.43743551 |
| 22 | Lymphopenia (HP:0001888) | 3.41116269 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 3.37818499 |
| 24 | Leukocytosis (HP:0001974) | 3.36167749 |
| 25 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.30797370 |
| 26 | Hemoptysis (HP:0002105) | 3.20107623 |
| 27 | Granulocytopenia (HP:0001913) | 3.18728548 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.10808118 |
| 29 | Recurrent sinusitis (HP:0011108) | 3.06298396 |
| 30 | Pustule (HP:0200039) | 3.04098987 |
| 31 | Eosinophilia (HP:0001880) | 3.00567869 |
| 32 | Petechiae (HP:0000967) | 3.00030366 |
| 33 | Gingivitis (HP:0000230) | 2.99932398 |
| 34 | Urticaria (HP:0001025) | 2.98254958 |
| 35 | Hypergammaglobulinemia (HP:0010702) | 2.91853679 |
| 36 | Chest pain (HP:0100749) | 2.91354425 |
| 37 | Inflammation of the large intestine (HP:0002037) | 2.90259060 |
| 38 | Colitis (HP:0002583) | 2.86282709 |
| 39 | Abnormality of eosinophils (HP:0001879) | 2.83505551 |
| 40 | Severe combined immunodeficiency (HP:0004430) | 2.80172726 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 2.79504570 |
| 42 | Aplastic anemia (HP:0001915) | 2.69941877 |
| 43 | Verrucae (HP:0200043) | 2.62567766 |
| 44 | Papilloma (HP:0012740) | 2.62567766 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.60278985 |
| 46 | Hypochromic anemia (HP:0001931) | 2.60094738 |
| 47 | IgM deficiency (HP:0002850) | 2.59074511 |
| 48 | Pulmonary embolism (HP:0002204) | 2.58532424 |
| 49 | Chronic diarrhea (HP:0002028) | 2.53020445 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.52737930 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 2.52274521 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.51936947 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.50800798 |
| 54 | Osteomyelitis (HP:0002754) | 2.48467742 |
| 55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.45827912 |
| 56 | Recurrent viral infections (HP:0004429) | 2.45137552 |
| 57 | Myositis (HP:0100614) | 2.45007801 |
| 58 | Anorexia (HP:0002039) | 2.43188807 |
| 59 | Bronchitis (HP:0012387) | 2.42738843 |
| 60 | Osteolytic defects of the hand bones (HP:0009699) | 2.39914473 |
| 61 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.39914473 |
| 62 | Gangrene (HP:0100758) | 2.39641918 |
| 63 | IgA deficiency (HP:0002720) | 2.38690995 |
| 64 | Abnormality of the pleura (HP:0002103) | 2.38645630 |
| 65 | Lymphoma (HP:0002665) | 2.36719883 |
| 66 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.35096509 |
| 67 | Restrictive lung disease (HP:0002091) | 2.34917181 |
| 68 | Multiple enchondromatosis (HP:0005701) | 2.34056578 |
| 69 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.33977153 |
| 70 | Abnormal number of erythroid precursors (HP:0012131) | 2.30876446 |
| 71 | Recurrent abscess formation (HP:0002722) | 2.30127682 |
| 72 | Increased muscle lipid content (HP:0009058) | 2.29773701 |
| 73 | Combined immunodeficiency (HP:0005387) | 2.29754578 |
| 74 | Hepatic necrosis (HP:0002605) | 2.28652536 |
| 75 | Rhabdomyolysis (HP:0003201) | 2.25053326 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 2.24755757 |
| 77 | Papilledema (HP:0001085) | 2.23918267 |
| 78 | Conjunctival hamartoma (HP:0100780) | 2.23322304 |
| 79 | Sepsis (HP:0100806) | 2.23232211 |
| 80 | Exertional dyspnea (HP:0002875) | 2.22131129 |
| 81 | Mucosal telangiectasiae (HP:0100579) | 2.22113159 |
| 82 | Joint swelling (HP:0001386) | 2.20916397 |
| 83 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.19675620 |
| 84 | Intrahepatic cholestasis (HP:0001406) | 2.18583723 |
| 85 | Recurrent bronchitis (HP:0002837) | 2.18223232 |
| 86 | Polyneuropathy (HP:0001271) | 2.18114114 |
| 87 | Abnormality of T cell physiology (HP:0011840) | 2.17325388 |
| 88 | Lipid accumulation in hepatocytes (HP:0006561) | 2.15955873 |
| 89 | Recurrent pneumonia (HP:0006532) | 2.15334528 |
| 90 | Skin rash (HP:0000988) | 2.14283236 |
| 91 | Reticulocytopenia (HP:0001896) | 2.13742184 |
| 92 | Emphysema (HP:0002097) | 2.13096652 |
| 93 | Recurrent lower respiratory tract infections (HP:0002783) | 2.12914663 |
| 94 | Microcytic anemia (HP:0001935) | 2.12490363 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 2.11527955 |
| 96 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.10858051 |
| 97 | Abnormality of alanine metabolism (HP:0010916) | 2.10858051 |
| 98 | Hyperalaninemia (HP:0003348) | 2.10858051 |
| 99 | Glomerulopathy (HP:0100820) | 2.10443802 |
| 100 | Abnormal platelet volume (HP:0011876) | 2.09665185 |
| 101 | Chronic otitis media (HP:0000389) | 2.07626447 |
| 102 | Deep venous thrombosis (HP:0002625) | 2.06798270 |
| 103 | Respiratory difficulties (HP:0002880) | 2.06506353 |
| 104 | Viral hepatitis (HP:0006562) | 2.06336274 |
| 105 | Vertebral compression fractures (HP:0002953) | 2.06089760 |
| 106 | Skin ulcer (HP:0200042) | 2.05726168 |
| 107 | Hypobetalipoproteinemia (HP:0003563) | 2.05707231 |
| 108 | Nonimmune hydrops fetalis (HP:0001790) | 2.05398996 |
| 109 | Impaired platelet aggregation (HP:0003540) | 2.03071577 |
| 110 | Abnormal platelet function (HP:0011869) | 2.03071577 |
| 111 | Abnormality of the prostate (HP:0008775) | 2.02772094 |
| 112 | Increased mean platelet volume (HP:0011877) | 2.02624669 |
| 113 | Generalized aminoaciduria (HP:0002909) | 2.01767176 |
| 114 | Hyperbilirubinemia (HP:0002904) | 2.00502358 |
| 115 | Nausea (HP:0002018) | 2.00367453 |
| 116 | Basal cell carcinoma (HP:0002671) | 1.98358465 |
| 117 | Fatigue (HP:0012378) | 1.97122073 |
| 118 | Arthralgia (HP:0002829) | 1.96268636 |
| 119 | Protrusio acetabuli (HP:0003179) | 1.95909856 |
| 120 | Abnormality of T cells (HP:0002843) | 1.94404807 |
| 121 | Abnormality of lateral ventricle (HP:0030047) | 1.94177062 |
| 122 | Abnormal cartilage morphology (HP:0002763) | 1.93832927 |
| 123 | Peritonitis (HP:0002586) | 1.93604409 |
| 124 | Cellulitis (HP:0100658) | 1.91110537 |
| 125 | Abnormality of T cell number (HP:0011839) | 1.90444453 |
| 126 | Xanthomatosis (HP:0000991) | 1.89970835 |
| 127 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89898450 |
| 128 | Dicarboxylic aciduria (HP:0003215) | 1.89898450 |
| 129 | Hepatocellular necrosis (HP:0001404) | 1.89065237 |
| 130 | Cervical subluxation (HP:0003308) | 1.88356614 |
| 131 | Lipoatrophy (HP:0100578) | 1.88036314 |
| 132 | Gastrointestinal infarctions (HP:0005244) | 1.87884745 |
| 133 | Epistaxis (HP:0000421) | 1.86967029 |
| 134 | Reduced antithrombin III activity (HP:0001976) | 1.86213687 |
| 135 | Increased hepatocellular lipid droplets (HP:0006565) | 1.85908344 |
| 136 | Purpura (HP:0000979) | 1.85513392 |
| 137 | Hypoglycemic coma (HP:0001325) | 1.84751499 |
| 138 | Exercise-induced muscle cramps (HP:0003710) | 1.84463621 |
| 139 | Acute myeloid leukemia (HP:0004808) | 1.84216691 |
| 140 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.82871944 |
| 141 | Myocardial infarction (HP:0001658) | 1.82245942 |
| 142 | IgG deficiency (HP:0004315) | 1.78362842 |
| 143 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.76975696 |
| 144 | Beaking of vertebral bodies (HP:0004568) | 1.76917236 |
| 145 | Gastrointestinal stroma tumor (HP:0100723) | 1.75727786 |
| 146 | Gingival bleeding (HP:0000225) | 1.75464299 |
| 147 | Abnormality of methionine metabolism (HP:0010901) | 1.74698486 |
| 148 | B lymphocytopenia (HP:0010976) | 1.74519846 |
| 149 | Abnormality of B cell number (HP:0010975) | 1.74519846 |
| 150 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.72676562 |
| 151 | Abnormality of iron homeostasis (HP:0011031) | 1.72591843 |
| 152 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.71687566 |
| 153 | Thrombophlebitis (HP:0004418) | 1.71415455 |
| 154 | Neoplasm of head and neck (HP:0012288) | 1.71120978 |
| 155 | Esophageal neoplasm (HP:0100751) | 1.71120978 |
| 156 | Increased serum ferritin (HP:0003281) | 1.70022526 |
| 157 | Conjunctival telangiectasia (HP:0000524) | 1.69784247 |
| 158 | T lymphocytopenia (HP:0005403) | 1.68773380 |
| 159 | Increased serum pyruvate (HP:0003542) | 1.68601507 |
| 160 | Abnormality of glycolysis (HP:0004366) | 1.68601507 |
| 161 | Ankle contracture (HP:0006466) | 1.66719549 |
| 162 | Eczematoid dermatitis (HP:0000976) | 1.65978186 |
| 163 | Hyperammonemia (HP:0001987) | 1.65744711 |
| 164 | Abnormality of the common coagulation pathway (HP:0010990) | 1.65254778 |
| 165 | Cupped ribs (HP:0000887) | 1.65016507 |
| 166 | Arterial thrombosis (HP:0004420) | 1.64915244 |
| 167 | Myoglobinuria (HP:0002913) | 1.63537916 |
| 168 | Autoimmune hemolytic anemia (HP:0001890) | 1.62546435 |
| 169 | Poor head control (HP:0002421) | 1.62527762 |
| 170 | Orchitis (HP:0100796) | 1.61723428 |
| 171 | Recurrent fungal infections (HP:0002841) | 1.61184626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.44665600 |
| 2 | ACVR1B | 3.01511369 |
| 3 | PRPF4B | 3.00952308 |
| 4 | NME2 | 2.93003365 |
| 5 | FES | 2.70538259 |
| 6 | CSK | 2.56686117 |
| 7 | BRSK2 | 2.50631887 |
| 8 | PIM2 | 2.27794633 |
| 9 | STK10 | 2.21950292 |
| 10 | EEF2K | 2.19156012 |
| 11 | TAOK3 | 2.12780305 |
| 12 | TYK2 | 2.10444172 |
| 13 | WEE1 | 2.09202419 |
| 14 | MAP2K3 | 2.02644342 |
| 15 | NEK9 | 1.99937846 |
| 16 | MAP4K1 | 1.91821896 |
| 17 | BUB1 | 1.87698139 |
| 18 | CDC7 | 1.84922985 |
| 19 | TGFBR1 | 1.76823408 |
| 20 | HCK | 1.76269370 |
| 21 | KIT | 1.69893029 |
| 22 | LRRK2 | 1.69810383 |
| 23 | PKN2 | 1.69447817 |
| 24 | RPS6KA4 | 1.66815631 |
| 25 | TNK2 | 1.64700196 |
| 26 | TTN | 1.64399435 |
| 27 | FLT3 | 1.62082625 |
| 28 | JAK3 | 1.62035663 |
| 29 | TRPM7 | 1.57688794 |
| 30 | ARAF | 1.54356149 |
| 31 | STK24 | 1.53950997 |
| 32 | BCKDK | 1.53392258 |
| 33 | RAF1 | 1.52122081 |
| 34 | EIF2AK1 | 1.51866928 |
| 35 | TRIB3 | 1.51359937 |
| 36 | TEC | 1.50084791 |
| 37 | MST4 | 1.47317375 |
| 38 | MAP3K3 | 1.44690196 |
| 39 | SIK3 | 1.41522787 |
| 40 | TBK1 | 1.36559534 |
| 41 | SCYL2 | 1.34109108 |
| 42 | ERN1 | 1.32868680 |
| 43 | ZAP70 | 1.30457052 |
| 44 | BMPR1B | 1.30377052 |
| 45 | FGFR4 | 1.25531457 |
| 46 | EPHB1 | 1.24269794 |
| 47 | MARK3 | 1.24145701 |
| 48 | PLK4 | 1.23205810 |
| 49 | MAP3K8 | 1.21019436 |
| 50 | MAP3K14 | 1.18060218 |
| 51 | BMPR2 | 1.17942418 |
| 52 | STK4 | 1.17665256 |
| 53 | STK3 | 1.16992537 |
| 54 | MAP3K13 | 1.13530941 |
| 55 | CSF1R | 1.13460565 |
| 56 | CCNB1 | 1.13214941 |
| 57 | BTK | 1.13070128 |
| 58 | IRAK1 | 1.12642113 |
| 59 | FGR | 1.11621883 |
| 60 | RPS6KB2 | 1.08944651 |
| 61 | MAP3K6 | 1.08833817 |
| 62 | PRKCQ | 1.07383274 |
| 63 | SIK2 | 1.01803088 |
| 64 | FGFR3 | 1.00913499 |
| 65 | VRK1 | 0.97588285 |
| 66 | PIM1 | 0.97326458 |
| 67 | MATK | 0.96483875 |
| 68 | EIF2AK3 | 0.95681522 |
| 69 | YES1 | 0.95625643 |
| 70 | BRSK1 | 0.92017934 |
| 71 | MAPK11 | 0.90858553 |
| 72 | MAP3K5 | 0.89212432 |
| 73 | IRAK2 | 0.89013039 |
| 74 | IRAK4 | 0.88350231 |
| 75 | AURKB | 0.86415294 |
| 76 | KSR2 | 0.85838864 |
| 77 | MUSK | 0.84328902 |
| 78 | ILK | 0.83612707 |
| 79 | NEK2 | 0.82140549 |
| 80 | SYK | 0.80753496 |
| 81 | CDK4 | 0.80540740 |
| 82 | ABL2 | 0.77967102 |
| 83 | JAK1 | 0.77626861 |
| 84 | NLK | 0.77187571 |
| 85 | PDK1 | 0.77017072 |
| 86 | CAMKK2 | 0.76488369 |
| 87 | MYLK | 0.76082710 |
| 88 | MAP3K1 | 0.75817862 |
| 89 | MAPK7 | 0.75763017 |
| 90 | TGFBR2 | 0.74960794 |
| 91 | TAOK1 | 0.73679008 |
| 92 | BLK | 0.73052208 |
| 93 | CDK19 | 0.70984275 |
| 94 | OBSCN | 0.69372582 |
| 95 | IKBKB | 0.69261360 |
| 96 | ZAK | 0.68886229 |
| 97 | MAPKAPK5 | 0.68638873 |
| 98 | CAMKK1 | 0.67705874 |
| 99 | ITK | 0.66763143 |
| 100 | MAPK12 | 0.65755105 |
| 101 | MAPKAPK3 | 0.62528682 |
| 102 | PRKCH | 0.62482411 |
| 103 | KDR | 0.59854614 |
| 104 | MAP3K11 | 0.59754356 |
| 105 | CDK6 | 0.58447884 |
| 106 | NUAK1 | 0.58190035 |
| 107 | TXK | 0.57910965 |
| 108 | NEK1 | 0.57589807 |
| 109 | CDC42BPA | 0.57562016 |
| 110 | CLK1 | 0.56809216 |
| 111 | MELK | 0.56671828 |
| 112 | PLK1 | 0.56088943 |
| 113 | JAK2 | 0.54436395 |
| 114 | LYN | 0.53821378 |
| 115 | STK16 | 0.53095195 |
| 116 | TIE1 | 0.52393438 |
| 117 | FRK | 0.52149552 |
| 118 | FYN | 0.51215047 |
| 119 | RIPK1 | 0.51117447 |
| 120 | TTK | 0.48539949 |
| 121 | HIPK2 | 0.48488737 |
| 122 | MAP3K10 | 0.47945044 |
| 123 | BRAF | 0.47739786 |
| 124 | MARK2 | 0.47361298 |
| 125 | PRKD2 | 0.46547696 |
| 126 | PASK | 0.46098957 |
| 127 | PTK2B | 0.45932912 |
| 128 | MAP3K7 | 0.45887603 |
| 129 | TAOK2 | 0.44767262 |
| 130 | PIK3CG | 0.44384839 |
| 131 | MAPK4 | 0.43801286 |
| 132 | DYRK3 | 0.43772434 |
| 133 | CHUK | 0.42696970 |
| 134 | PBK | 0.42145774 |
| 135 | LCK | 0.42034952 |
| 136 | ATR | 0.41085502 |
| 137 | IKBKE | 0.40975692 |
| 138 | CDK8 | 0.39860028 |
| 139 | GRK6 | 0.39576047 |
| 140 | MOS | 0.39529474 |
| 141 | PDPK1 | 0.35919275 |
| 142 | SGK2 | 0.35735064 |
| 143 | MAPKAPK2 | 0.32823074 |
| 144 | EPHA3 | 0.29472943 |
| 145 | TYRO3 | 0.28795670 |
| 146 | NEK6 | 0.26310190 |
| 147 | SGK3 | 0.25846262 |
| 148 | EGFR | 0.25271700 |
| 149 | STK11 | 0.24787530 |
| 150 | RPS6KL1 | 0.22766774 |
| 151 | RPS6KC1 | 0.22766774 |
| 152 | CDK12 | 0.20074310 |
| 153 | MAP2K2 | 0.19752705 |
| 154 | SMG1 | 0.19706061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.49188794 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.32042332 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.29146135 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.15658599 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.45807971 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.35031054 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.34009790 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.13735694 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.12607358 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.08563181 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.05640146 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02663545 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87989881 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.87043176 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.84479617 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.82535677 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 1.75323426 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.71495628 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.65999795 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 1.58677357 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57928399 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.57171400 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.55706908 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55499738 |
| 25 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.47320356 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45663270 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43357024 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 1.42946482 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.42432796 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41745424 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41300393 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.39820273 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.37396847 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.36941858 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.33316010 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32663701 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31138907 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30686189 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30568795 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28438682 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27042882 |
| 42 | RNA polymerase_Homo sapiens_hsa03020 | 1.26999074 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.24346294 |
| 44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.24051854 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16111869 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14722359 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13622758 |
| 48 | RNA degradation_Homo sapiens_hsa03018 | 1.12953488 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12302575 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10512277 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.08985483 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 1.08026670 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07430680 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06736040 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.05261580 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.05234662 |
| 57 | Protein export_Homo sapiens_hsa03060 | 1.04746891 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.04205793 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04124336 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.03710963 |
| 61 | Measles_Homo sapiens_hsa05162 | 1.00476050 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.99826338 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99112860 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99016930 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98950843 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.98110111 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94987858 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.94773218 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94263866 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.93622499 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91779987 |
| 72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.91199660 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89604182 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89556920 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88714942 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87674273 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86931436 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86875522 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86785527 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.86217333 |
| 81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.85352178 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85160144 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.81594914 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.79988481 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79318446 |
| 86 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79093054 |
| 87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77112719 |
| 88 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76697153 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.76428391 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76161973 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75652790 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74892797 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74080211 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73003327 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72894702 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.72489409 |
| 97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71453840 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71052337 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70883274 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70744625 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70016298 |
| 102 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.69980596 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68878736 |
| 104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68550988 |
| 105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68304528 |
| 106 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67862835 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67319749 |
| 108 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66381341 |
| 109 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66348489 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66175486 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65623811 |
| 112 | RNA transport_Homo sapiens_hsa03013 | 0.65445201 |
| 113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64049358 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63224437 |
| 115 | Malaria_Homo sapiens_hsa05144 | 0.63057720 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61569799 |
| 117 | Spliceosome_Homo sapiens_hsa03040 | 0.61211378 |
| 118 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60975147 |
| 119 | Purine metabolism_Homo sapiens_hsa00230 | 0.60780328 |
| 120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60653184 |
| 121 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60102789 |
| 122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59695970 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58549123 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57391463 |
| 125 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56090098 |
| 126 | Influenza A_Homo sapiens_hsa05164 | 0.56031490 |
| 127 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53327341 |
| 128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52671005 |
| 129 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52635505 |
| 130 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51840540 |
| 131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51251391 |
| 132 | Salmonella infection_Homo sapiens_hsa05132 | 0.51004896 |
| 133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50064508 |
| 134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49788516 |
| 135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49550284 |
| 136 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49018204 |
| 137 | Shigellosis_Homo sapiens_hsa05131 | 0.48320121 |
| 138 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47473807 |
| 139 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46220605 |
| 140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46104172 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45131092 |
| 142 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44052590 |
| 143 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43086816 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42368502 |
| 145 | Prostate cancer_Homo sapiens_hsa05215 | 0.42145068 |
| 146 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41798209 |
| 147 | Endocytosis_Homo sapiens_hsa04144 | 0.38106016 |
| 148 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33136233 |
| 149 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33070660 |
| 150 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32147662 |
| 151 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29855217 |
| 152 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28032480 |
| 153 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28013210 |
| 154 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27826933 |
| 155 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26961157 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25735795 |
| 157 | Insulin resistance_Homo sapiens_hsa04931 | 0.24223693 |
| 158 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23923886 |
| 159 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23524787 |
| 160 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.23174307 |
| 161 | Amoebiasis_Homo sapiens_hsa05146 | 0.19535551 |
| 162 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.17369198 |
| 163 | Glioma_Homo sapiens_hsa05214 | 0.15600806 |
| 164 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14289906 |
| 165 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.13379603 |
| 166 | Long-term potentiation_Homo sapiens_hsa04720 | 0.13283187 |
| 167 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.13011627 |

